A carregar...
Advances in and applications of proteasome inhibitors
With the recent US Food and Drug Administration approval of bortezomib (Velcade®) for the treatment of relapsed multiple myeloma, the proteasome has emerged as a new therapeutic target with diverse pathology. Drug discovery programs in academia and the pharmaceutical industry have developed a range...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2560982/ https://ncbi.nlm.nih.gov/pubmed/18656549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cbpa.2008.06.033 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|